J. V. van Nimwegen

发表

Safety of treatments for primary Sjögren’s syndrome

A. Vissink, H. Bootsma, E. Brouwer, 2016, Expert opinion on drug safety.

THU0239 IDENTIFICATION OF BIOMARKERS AND IMMUNE PATHWAYS FOR PERSONALIZED DRUG TARGETING IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY SJÖGREN’S SYNDROME

A. Vissink, S. Kirov, H. Bootsma, 2019, Poster Presentations.

Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren’s syndrome

A. Vissink, H. Bootsma, B. Hazenberg, 2018, Rheumatology.

The value of rituximab treatment in primary Sjögren's syndrome.

A. Vissink, H. Bootsma, J. V. van Nimwegen, 2017, Clinical immunology.

Ultrasound of the Major Salivary Glands is a Reliable Imaging Technique in Patients with Clinically Suspected Primary Sjögren’s Syndrome

A. Vissink, P. Dijkstra, F. Spijkervet, 2017, Ultraschall in der Medizin - European Journal of Ultrasound.

Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial.

A. Vissink, F. Spijkervet, H. Bootsma, 2022, Seminars in arthritis and rheumatism.

Validation of the ACR-EULAR criteria for primary Sjögren’s syndrome in a Dutch prospective diagnostic cohort

A. Vissink, F. Spijkervet, H. Bootsma, 2018, Rheumatology.

The parotid gland connection: ultrasound and biopsies in primary Sjögren’s syndrome

A. Vissink, F. Spijkervet, H. Bootsma, 2017, Annals of the rheumatic diseases.

Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren’s syndrome?

A. Vissink, F. Spijkervet, H. Bootsma, 2018, Annals of the rheumatic diseases.

Vaginal dryness in primary Sjögren’s syndrome: a histopathological case–control study

A. Vissink, H. Hollema, H. Bootsma, 2020, Rheumatology.

Histopathology, salivary flow and ultrasonography of the parotid gland: three complementary measurements in primary Sjögren’s syndrome

A. Vissink, F. Spijkervet, H. Bootsma, 2021, Rheumatology.

Scoring hypoechogenic areas in one parotid and one submandibular gland increases feasibility of ultrasound in primary Sjögren’s syndrome

A. Vissink, F. Spijkervet, H. Bootsma, 2017, Annals of the rheumatic diseases.

Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren’s syndrome

A. Vissink, F. Spijkervet, H. Bootsma, 2017, Annals of the rheumatic diseases.

Aging and Immunopathology in Primary Sjögren's Syndrome.

A. Vissink, H. Bouma, F. Spijkervet, 2015, Current aging science.

Clinical Phenotyping of Primary Sjögren Syndrome Patients Using Salivary Gland Ultrasonography: Data From the RESULT Cohort

A. Vissink, H. Bootsma, E. Mossel, 2020, The Journal of Rheumatology.

Patient Acceptable Symptom State (PASS) in patients with primary Sjögren's syndrome in daily clinical practice.

A. Vissink, H. Bootsma, E. Mossel, 2022, Clinical and experimental rheumatology.

The impact of primary Sjögren's syndrome on female sexual function.

A. Vissink, H. Bootsma, J. V. van Nimwegen, 2014, Rheumatology.

Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjögren's syndrome patients.

A. Vissink, F. Spijkervet, H. Bootsma, 2019, Clinical and experimental rheumatology.

Ten years of the ESSDAI: is it fit for purpose?

H. Bootsma, J. V. van Nimwegen, S. Arends, 2020, Clinical and experimental rheumatology.

OP0045 ABATACEPT TREATMENT OF PATIENTS WITH EARLY ACTIVE PRIMARY SJÖGREN’S SYNDROME – A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED PHASE

A. Vissink, F. Spijkervet, H. Bootsma, 2019, Oral Presentations.

Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure.

A. Vissink, J. Gottenberg, H. Bootsma, 2021, The Lancet. Rheumatology.